Author

P. Davis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Approach:benchmark study· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:CITE-seq· 1 Research Focus:database / resource· 1

Frequent Co-Authors

A. Acha-Sagredo· 1 shared A. Andama· 1 shared A. Enrriques· 1 shared A. Pinter· 1 shared A. Strange· 1 shared C. Coletti· 1 shared C. S. Lim· 1 shared C. Sundling· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Acha-Sagredo

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Structure-Property-Processing Correlations of Graphene Bioscaffolds for Proliferation and Differentiation of C2C12 Cells

L. Karriem, J. Eixenberger, S. Frahs, D. Convertino, T. Webb, T. Pandhi, K. McLaughlin, A. Enrriques, P. Davis, H. Subbaraman, C. Coletti, J. Oxford, D. Estrada

This study examines how different graphene bioscaffold production methods affect C2C12 cell morphology, gene expression, and differentiation.

bioRxiv · Apr 25, 2023 · PreprintBioengineering

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

J. L. Cantera, L. M. Lillis, R. B. Peck, E. Moreau, J. A. Schouten, P. Davis, P. K. Drain, A. Andama, A. Pinter, M. Kawasaki, G. Kallenius, C. Sundling, K. M. Dobos, D. Flores, D. Chatterjee, , D. S. Boyle

This study evaluates new LAM-specific antibodies for TB diagnosis, finding that while some show strong binding to cultured LAM, their performance with urinary LAM varies, and no new antibodies outperform existing ones in clinical samples.

bioRxiv · Apr 12, 2022Microbiology

Combinatorial T cell engineering eliminates on-target off-tumor toxicity of CD229 CAR T cells while maintaining anti-tumor activity.

E. R. Vander Mause, J. M. Baker, K. A. Dietze, S. V. Radhakrishnan, M. L. Olson, T. Iraguha, P. Davis, J. Panse, J. E. Marvin, M. Steinbach, D. P. Ng, C. S. Lim, D. Atanackovic, T. Luetkens

The paper engineers low-affinity CD229 CAR T cells with CJUN overexpression to reduce on-target off-tumor toxicity while preserving anti-tumor activity.

bioRxiv · Dec 6, 2021 · PreprintBioengineering

Comparative assessment of genes driving cancer and somatic evolution.

L. Dressler, M. Bortolomeazzi, M. R. Keddar, H. Misetic, G. Sartini, A. Acha-Sagredo, L. Montorsi, N. Wijewardhane, D. Repana, J. Nulsen, J. Goldman, M. Pollit, P. Davis, A. Strange, K. Ambrose, F. D. Ciccarelli

The paper assesses genes driving cancer and somatic evolution, revealing gaps in driver gene compendiums and identifying conserved genes that promote clonal expansion without malignancy.

bioRxiv · Aug 31, 2021 · PreprintCancer Biology